1/17
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Menopause: Definition
Amenorrhea (12 months) after final menstrual period (FMP)
Ovarian function loss
Onset: 45-56 years
Menopause: Ovary Changes in Amenorrhea
Decreased ovarian follicles (age) = Decrease estrogen + progesterone = Decrease negative feedback on pituitary gland
Hypergonadotropic Hypogonadism*: Increase GnRH = Increase FSH/LH
Increase anovulatory cycles
Menopause: Ovary Changes in Vasomotor Symptoms
Low estrogen = Increase norepinephrine + decrease serotonin = Decrease hypothalamus thermoregulation efficacy
Small temp changes = Big compensatory response
Hot flashes
Heat intolerance
Increased sweating
Menopause: Ovary Changes in GU Symptoms
Low estrogen = Atrophy of…
Vagina
Vulva
Urethra
Bladder
Vulvovaginal atrophy = Dryness, pruritus, dyspareunia (pain from intercourse)
Lower urinary tract atrophy = Dysuria, incontinence
Menopause: Management
Lifestyle changes
Hormone therapy
Menopause Management: Lifestyle Changes
Vasomotor symptoms
Diet changes (no caffeine, spicy foods, alcohol)
Controlling temp (fans, layering clothes)
Decrease stress
GU symptoms
Vaginal lubricants + moisturizers
Menopause Management: Hormone Therapy
Systemic:
No uterus: Estrogen-only
With uterus: Estrogen + endometrial protection agent (progestin)
Intravaginal:
Estrogen (Cream, gel capsule, ring)
DHEA (prasterone)
Menopause Hormone Therapy: Indications
Premature menopause
Severe symptoms
< 60 years
Menopause for < 10 years
Menopause Hormone Therapy: Benefits
Symptom relief
Osteoporosis prevention
Menopause Hormone Therapy: Risks
Thromboembolic events
Estrogen-sensitive cancer
Mood swings
Headaches
GI upset
Breakthrough bleeding
Menopause: Complications
CAD + central obesity**
Estrogen = Decrease cardiovascular risk
Increase TAG, LDL, weight, HTN
Osteoporosis
Low estrogen = Decrease bone formation
Postmenopausal Bleeding: Description
Vaginal bleeding ≥ 12 months after FMP (not on hormone therapy)
Postmenopausal Bleeding: Etiology
GU symptoms
Vaginal dryness + friability
STIs
Endometrial polyps
Endometrial hyperplasia
Cancer
Endometrial
Cervical
Postmenopausal Bleeding: Investigations
Hormone testing
Transvaginal US
Hysteroscopy**
Postmenopausal Bleeding Investigations: Hormone Testing
GU: Increased FSH
Postmenopausal Bleeding Investigations: Transvaginal US
Polyps: Echogenic endometrial mass
Endometrial Hyperplasia/Cancer: Endometrial thickening > 4mm
Postmenopausal Bleeding Investigations: Hysteroscopy
Polyps
Endometrial hyperplasia: + biopsy
Cervical cancer: + biopsy
Postmenopausal Bleeding: Treatment
GU:
Vaginal moisturizers + lubricants
Hormone therapy
Polyps:
Asymptomatic: Monitor
Polypectomy
Hyperplasia:
Decrease estrogen → Treat PCOS, obesity
Progestin + monitoring
Hysterectomy
Cancer:
Hysterectomy
Chemotherapy
Radiotherapy